Procter & Gamble (NYSE:PG - Get Free Report) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of 6.830-7.090 for the period, compared to the consensus earnings per share estimate of 6.950. The company issued revenue guidance of $85.1 billion-$88.5 billion, compared to the consensus revenue estimate of $86.6 billion.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Rothschild & Co Redburn upped their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a "neutral" rating in a research note on Friday, January 23rd. Jefferies Financial Group lowered their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating for the company in a report on Monday. Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $177.00 to $158.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. Royal Bank Of Canada reduced their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating on the stock in a report on Thursday, April 9th. Finally, Barclays decreased their price objective on shares of Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 14th. Twelve equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $162.37.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Stock Performance
Shares of PG opened at $145.77 on Friday. The stock has a 50 day moving average price of $150.56 and a 200 day moving average price of $148.72. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $338.77 billion, a price-to-earnings ratio of 21.60, a price-to-earnings-growth ratio of 5.50 and a beta of 0.41. Procter & Gamble has a 52-week low of $137.62 and a 52-week high of $170.99.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.53 by $0.06. The company had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble will post 6.96 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be given a $1.0885 dividend. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble's payout ratio is 62.67%.
Insider Transactions at Procter & Gamble
In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the business's stock in a transaction on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the completion of the sale, the chief executive officer directly owned 1,029 shares of the company's stock, valued at $170,083.41. The trade was a 84.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 36,093 shares of the firm's stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total value of $5,858,976.69. Following the transaction, the chief executive officer directly owned 34,994 shares in the company, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 252,715 shares of company stock valued at $40,966,904 over the last quarter. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Q3 EPS topped estimates: P&G reported $1.59 EPS vs. $1.53 consensus and sales grew ~7%, showing resilient pricing/margin execution. Management reiterated its full‑year outlook. CNBC: Procter & Gamble earnings beat estimates as sales grow 7%
- Positive Sentiment: Brand/product momentum: P&G earned top spot in Fortune’s “Most Innovative Companies” for household products and launched new Febreze TRASH, supporting long‑term organic growth and innovation premium. Fortune recognition Febreze TRASH launch
- Neutral Sentiment: Market previews and commentary set modest expectations going into results; macro/consumer‑sentiment data remain the bigger cyclical risk for staples demand. Yahoo: Earnings, consumer sentiment preview
- Neutral Sentiment: Corporate housekeeping: P&G management publicly refuted a mini‑tender offer (minor market noise, not operational). Yahoo: Mini‑tender discussion
- Negative Sentiment: FY‑2026 guidance came in slightly below Street: EPS guided to $6.83–$7.09 (consensus ~6.95) and revenue guidance midpoint a touch under consensus — this cut in expected growth/beat cadence is the primary driver of the selloff. MarketBeat: Q3 results & guidance
- Negative Sentiment: Quarterly revenue missed estimates ($21.23B vs. $21.52B), suggesting volume weakness offset by pricing — an earnings‑quality concern for some investors. CNBC: Revenue miss details
- Negative Sentiment: Analysts trimmed targets/ratings after the print and guidance (Morgan Stanley, BNP Paribas Exane, BofA among firms lowering PTs), increasing near‑term downside risk from multiple sell‑side revisions. MarketScreener: BNP Paribas PT cut MarketScreener: Morgan Stanley PT cut InsiderMonkey: BofA resin‑cost note
Hedge Funds Weigh In On Procter & Gamble
A number of hedge funds have recently modified their holdings of the business. Brighton Jones LLC grew its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after purchasing an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. raised its holdings in shares of Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock valued at $493,000 after buying an additional 277 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company's stock valued at $979,000 after buying an additional 1,016 shares during the last quarter. Auxano Advisors LLC boosted its stake in shares of Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company's stock worth $1,165,000 after buying an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. grew its holdings in shares of Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company's stock worth $4,809,000 after buying an additional 809 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
About Procter & Gamble
(
Get Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
